Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
doi: 10.1001/jamainternmed.2023.7268
99 , 24572466 (2014) S
SLU-PP-332 is currently in development and not yet available for patient use
In recent research, ginger, and its active compound gingerol, have shown potential in modulating GLP-1 activity, improving insulin response and managing blood glucose through a variety of pathways
This product has not been independently tested for efficacy or safety, but each ingredient has been scientifically studied and shown to safely deliver positive results and improve the conditions noted
They also suppress the production of glucagon, a hormone that raises blood glucose
US$ 25.70
US$ 21.54
US$ 23.60
US$ 23.19
US$ 28.56
US$ 28.30
